Brooks O'Neil
Stock Analyst at Lake Street
(0.67)
# 4,159
Out of 5,245 analysts
35
Total ratings
29.41%
Success rate
-19.69%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFVN LifeVantage | Downgrades: Hold | $5 | $5.61 | -10.87% | 2 | May 7, 2026 | |
| MDXG MiMedx Group | Maintains: Buy | $12 → $10 | $3.62 | +176.24% | 2 | Jan 20, 2026 | |
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $4.19 | +90.93% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $14.97 | -19.81% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $4.58 | +74.67% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $13.20 | +51.52% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $97.75 | +12.53% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $11.82 | +153.81% | 1 | Feb 24, 2025 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $33.00 | +66.67% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $8.27 | +117.65% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $8.95 | +123.46% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.66 | +87.97% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $38.22 | -31.97% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $330 | $4.34 | +7,503.69% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $16.69 | +663.93% | 1 | Sep 15, 2020 |
LifeVantage
May 7, 2026
Downgrades: Hold
Price Target: $5
Current: $5.61
Upside: -10.87%
MiMedx Group
Jan 20, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $3.62
Upside: +176.24%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.19
Upside: +90.93%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $14.97
Upside: -19.81%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.58
Upside: +74.67%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $13.20
Upside: +51.52%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $97.75
Upside: +12.53%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $11.82
Upside: +153.81%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $33.00
Upside: +66.67%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $8.27
Upside: +117.65%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $8.95
Upside: +123.46%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $2.66
Upside: +87.97%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $38.22
Upside: -31.97%
Apr 8, 2022
Initiates: Buy
Price Target: $330
Current: $4.34
Upside: +7,503.69%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $16.69
Upside: +663.93%